MRS. DEBORAH DAWN SMITH, N.P
Nursing at Hillandale Rd, Durham, NC

License number
North Carolina 5004560
Category
Nursing
Type
Family
Address
Address
1901 Hillandale Rd SUITE F, Durham, NC 27705
Phone
(919) 383-1854
(919) 384-7089 (Fax)

Professional information

Deborah Smith Photo 1

Dr. Deborah Smith, Durham NC - MD (Doctor of Medicine)

Specialties:
Nursing (Nurse Practitioner), Obstetrics & Gynecology
Address:
2100 Erwin Rd, Durham 27705
(919) 620-4467 (Phone)
Languages:
English


Deborah J Smith Photo 2

Deborah J Smith, Durham NC

Specialties:
Obstetrics & Gynecology
Work:
Duke Univ. Medical Center
2100 Erwin Rd, Durham, NC 27705
Education:
University of North Carolina


Deborah D Smith Photo 3

Deborah D Smith, Durham NC - NP (Nurse practitioner)

Specialties:
Nursing (Nurse Practitioner)
Address:
1901 Hillandale Rd SUITE F, Durham 27705
(919) 383-1854 (Phone), (919) 384-7089 (Fax)
Languages:
English


Deborah Smith Photo 4

Deborah Smith

Location:
Durham, North Carolina
Industry:
Higher Education
Skills:
Ophthalmology, Healthcare, Surgery, Medical Devices, Clinical Trials, Pediatrics, Clinical Research


Deborah Smith Photo 5

Deborah Smith - Durham, NC

Work:
BIOGEN IDEC - Cambridge, MA
Global research, development
Semiconductor Production Specialist - Durham, NC CELESTICA, INC - Raleigh, NC
Manufacturing Manager
FLEXTRONICS INTERNATIONAL - Youngsville, NC
Senior Production Supervisor
NORTEL NETWORKS - Research Triangle Park, NC
Recognized leader
Education:
Durham Technical Community College - Durham, NC
Biowork
North Carolina Central University - Durham, NC
BA in English


Deborah Smith Photo 6

Methods For Administering Anti-Il-5 Antibodies

US Patent:
2010008, Apr 8, 2010
Filed:
Apr 30, 2008
Appl. No.:
12/598309
Inventors:
Bela Rajiv Patel - King of Prussia PA, US
Deborah Smith - Durham NC, US
Debra J. Tompson - King of prussia PA, US
Parnian Zia-Amirhosseini - Thousand Oaks CA, US
Assignee:
SmithKline Beecham Corporation - Philadelphia PA
International Classification:
A61K 39/395
US Classification:
4241331, 4241581
Abstract:
The present invention relates generally to the methods for the treatment and diagnosis of conditions mediated by IL-5 and excess eosinophil production, and more specifically to mAbs, Fabs, chimeric and humanized antibodies. More particularly, methods are provided for reducing eosinophils in a human in need thereof, which method comprises administering to said human a composition comprising at least one anti-IL-5 antibody, wherein at least one anti-IL-5 antibody provides a mean maximum plasma concentration of said anti-IL-5 antibody of at least about 1.03±0.21 μg/mL, an Area Under the Curve value of at least about 15.5±2.7 μg/day/mL and a serum half-life of about 16.2±2.1 days to about 21.7±2.8 days.